Possibility and prospects of using colchicine in patients with COVID-19, review update


如何引用文章

全文:

开放存取 开放存取
受限制的访问 ##reader.subscriptionAccessGranted##
受限制的访问 订阅或者付费存取

详细

There are theoretical prerequisites for the use of colchicine in the treatment of patients with COVID-19, and clinical studies are underway. To date, there is only limited published data indicating the potential efficacy of colchicine for COVID-19. These data do not yet allow to recommend it for general practice. When using colchicine, it is important to perform clinical and hematologic control and avoid drug interactions.

全文:

受限制的访问

作者简介

Yu. Kiselev

Oslo Metropolitan University

Norway

A. Matveev

Russian Medical Academy of Continuous Professional Education

Moscow, Russia

参考

  1. URL: https://gris.rosminzdrav.ru/.
  2. URL: https://www.medicines.org.uk/emc/ product/6415/smpc.
  3. Misawa T, Takahama M., Kozaki T., et ai. Microtubuie-driven spatial arrangement of mitochondria promotes activation of the NLRP3 infiammasome. Nat Immunoi. 2013;14:454-60.
  4. Hemkens L.G., Ewaid H, Gioy V.L., et ai. Coichicine for prevention of cardiovascuiar events. Cochrane Database Syst Rev. 2016;1:CD011047. doi: 10.1002/14651858.CD011047.pub2.
  5. Tardif J.C., Kouz S, Waters D.D., et ai. Efficacy and Safety of Low-Dose Coichicine after Myocardiai Infarction. N Engi J Med. 2019;381(26):2497-505. doi: 10.1056/NEJMoa1912388.
  6. Leung Y.Y., Hui L.L.Y, Kraus V.B. Coichicine-update on mechanism of action and therapeutic uses. Semin Arthr Rheum. 2015;45:341-50. doi: 10.1016/j.semarthrit.2015.06.013.
  7. Miiewska A., Nowak P, Owczarek K., et ai. Entry of human coronavirus NL63 into the ceil. J Virol. 2018;92:e01933-17. Doi: 10.1128/ JVi.01933-17.
  8. Guitekin N, Kucukates E. Microtubule inhibition therapy by colchicine in severe myocarditis especially caused by Epstein-Barr and cytomegalovirus co-infection during a two-year period: a novel therapeutic approach. J Pak Med Assoc. 2014;64:1420-23.
  9. Piantoni S., Patroni A., Toniati P, et al. Why not to use colchicine in COViD-19? An old antiinflammatory drug for a novel auto-inflammatory disease [published online ahead of print, 2020 May 30]. Rheumatol. (Oxford). 2020;keaa217. doi: 10.1093/rheumatobgy/keaa217.
  10. Nasiripour S., Zamani F, Farasatinasab M. Can Colchicine as an Old Anti-inflammatory Agent Be Effective in COViD-19? [Publish on-line ahead of print, 2020 May 23]. J Clin Pharmacol. 2020; 10:1002/jcph. 1 645. Doi: 10.1002/ jcph.1645.
  11. URL: https://covid19evidence.net.au/.
  12. URL: https://www.covid19treatmentguidelines. nih.gov/
  13. URL: https://static-0.minzdrav.gov.ru/system/ attachments/attaches/000/054/662/original/% D0%92%D1%80%D0%B5%D0%BC%D0%B5% D0%BD%D0%BD%D1%8B%D0%B5_%D0%9C %D0%A0_COViD-19_%28v.10%29.pdf.
  14. URL: https://www.canada.ca/en/public-health/ services/diseases/2019-novel-coronavirus-infection/ciinicai-management-covid-19.htmi.
  15. URL: https://www.ncbi.nlm.nih.gov/pmc/artides/ PMC7097833/pdf/idr-12-1-8543.pdf.
  16. URL: http://mc.msu.ru/protokol-COViD-MNOC. pdf?fbdid=iwAR0pcfEk_LpYL8O6YKNGEbe3b_ FuEpYTbiap8JTH6ZhnVjYLzTFtHBKpYNY
  17. Della-Torre E., Della-Torre F, Kusanovic Pcp M., et al. Treating COViD-19 with colchicine in community healthcare setting [Publish. On-line ahead of print, 2020 May 31]. Clin immunol. 2020;108490. doi: 10.1016/j.clim.2020.108490.
  18. Cumhur Cure M., Kucuk A., Cure E. Colchicine may not be effective in COViD-19 infection; it may even be harmful? [Publish. on-line ahead of print, 2020 May 11]. Clin Rheumatol. 2020;1-2. doi: 10.1007/s10067-020-05144-x.
  19. Gendelman O., Amital H., Bragazzi N.L., et al. Continuous hydroxychloroquine or colchicine therapy does not prevent infection with SARS- CoV-2: insights from a large healthcare database analysis. Autoimmun Rev. 2020;19(7):102566. doi: 10.1016/j.autrev.2020.102566.
  20. URL: https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/ colchicine-marketed-colcrys-information.
  21. URL: https://dinicaitriais.gov/ct2/resuits?co nd=COViD&term=colchicine&cntry=&state= &city=&dist=.
  22. Reyes A.Z., Hu K.A., Teperman J., et alAnti-inflammatory therapy for COViD-19 infection: the case for colchicine. Ann Rheum Dis. [Publish on-line First: 08 December 2020.]. Doi: 10.1136/ annrheumdis-2020-219174.
  23. URL: https://www.medrxiv.org/content/10.1101 /2021.01.26.21250494v1.full.pdf.
  24. Lopes M.i., Bonjorno L.P, Giannini M.C., et alBeneficial effects of colchicine for moderate to severe COViD-19: a randomised, double-blinded, placebo-controlled clinical trial. RMD Open. 2021;7:e001455. Doi: 10.1136/ rmdopen-2020-001455.
  25. URL: https://www.recoverytrial.net/news/ colchicine-to-be-investigated-as-a-possible-treatment-for-covid-19-in-the-recovery-trial.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Bionika Media, 2021
##common.cookie##